We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Tenet Healthcare (THC) Rises Higher Than Market: Key Facts
Read MoreHide Full Article
In the latest trading session, Tenet Healthcare (THC - Free Report) closed at $175.14, marking a +1.01% move from the previous day. This change outpaced the S&P 500's 0.54% gain on the day. On the other hand, the Dow registered a gain of 0.52%, and the technology-centric Nasdaq increased by 0.74%.
Prior to today's trading, shares of the hospital operator had gained 3.47% outpaced the Medical sector's loss of 2.12% and lagged the S&P 500's gain of 4.2%.
The upcoming earnings release of Tenet Healthcare will be of great interest to investors. The company's earnings report is expected on July 22, 2025. The company's upcoming EPS is projected at $2.82, signifying a 22.08% increase compared to the same quarter of the previous year. Simultaneously, our latest consensus estimate expects the revenue to be $5.15 billion, showing a 0.85% escalation compared to the year-ago quarter.
THC's full-year Zacks Consensus Estimates are calling for earnings of $12.75 per share and revenue of $20.9 billion. These results would represent year-over-year changes of +7.32% and +1.12%, respectively.
It is also important to note the recent changes to analyst estimates for Tenet Healthcare. Recent revisions tend to reflect the latest near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 0.15% upward. At present, Tenet Healthcare boasts a Zacks Rank of #3 (Hold).
From a valuation perspective, Tenet Healthcare is currently exchanging hands at a Forward P/E ratio of 13.6. This expresses a premium compared to the average Forward P/E of 11.18 of its industry.
It is also worth noting that THC currently has a PEG ratio of 1.26. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. As of the close of trade yesterday, the Medical - Hospital industry held an average PEG ratio of 1.26.
The Medical - Hospital industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 205, placing it within the bottom 18% of over 250 industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow THC in the coming trading sessions, be sure to utilize Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Tenet Healthcare (THC) Rises Higher Than Market: Key Facts
In the latest trading session, Tenet Healthcare (THC - Free Report) closed at $175.14, marking a +1.01% move from the previous day. This change outpaced the S&P 500's 0.54% gain on the day. On the other hand, the Dow registered a gain of 0.52%, and the technology-centric Nasdaq increased by 0.74%.
Prior to today's trading, shares of the hospital operator had gained 3.47% outpaced the Medical sector's loss of 2.12% and lagged the S&P 500's gain of 4.2%.
The upcoming earnings release of Tenet Healthcare will be of great interest to investors. The company's earnings report is expected on July 22, 2025. The company's upcoming EPS is projected at $2.82, signifying a 22.08% increase compared to the same quarter of the previous year. Simultaneously, our latest consensus estimate expects the revenue to be $5.15 billion, showing a 0.85% escalation compared to the year-ago quarter.
THC's full-year Zacks Consensus Estimates are calling for earnings of $12.75 per share and revenue of $20.9 billion. These results would represent year-over-year changes of +7.32% and +1.12%, respectively.
It is also important to note the recent changes to analyst estimates for Tenet Healthcare. Recent revisions tend to reflect the latest near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 0.15% upward. At present, Tenet Healthcare boasts a Zacks Rank of #3 (Hold).
From a valuation perspective, Tenet Healthcare is currently exchanging hands at a Forward P/E ratio of 13.6. This expresses a premium compared to the average Forward P/E of 11.18 of its industry.
It is also worth noting that THC currently has a PEG ratio of 1.26. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. As of the close of trade yesterday, the Medical - Hospital industry held an average PEG ratio of 1.26.
The Medical - Hospital industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 205, placing it within the bottom 18% of over 250 industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow THC in the coming trading sessions, be sure to utilize Zacks.com.